42nd week of 2009 patent applcation highlights part 31 |
Patent application number | Title | Published |
20090258026 | ANTI-NOTCH1 NRR ANTIBODIES AND METHODS USING SAME - The invention provides anti-Notch1 NRR antibodies, and compositions comprising and methods of using these antibodies. | 2009-10-15 |
20090258027 | Methods of modulating immune function - The invention relates to methods for modulating the immune function through targeting of CLIP molecules as well as gamma delta T cells. The result is wide range of new therapeutic regimens for treating, inhibiting the development of, or otherwise dealing with, a multitude of illnesses and conditions, including autoimmune disease, transplant and cell graft rejection, cancer, bacterial infection, HIV infection, and AIDS, as well as novel methods of diagnosis and of introducing a treatment regimen into a subject. | 2009-10-15 |
20090258028 | Methods Of Forming Coatings For Implantable Medical Devices For Controlled Release Of A Peptide And A Hydrophobic Drug - This invention is generally related to methods of forming coatings for implantable medical devices, such as drug delivery vascular stents. The methods are for forming coatings to control the release of a peptide such as RGD, and a hydrophobic drug. Both single layer and multiple layer coating constructs are encompassed in the various embodiments of the present invention. | 2009-10-15 |
20090258029 | Heparin Prodrugs and Drug Delivery Stents Formed Therefrom - A prodrug comprising a heparin and a drug is provided. The prodrug can be used to form a coating on a medical device. The prodrug can also be used with a polymeric material to form a coating on a medical device. The polymeric material can be a hydrophobic polymer, a hydrophilic polymer, a non-fouling polymer, or combinations thereof. The medical device can be implanted in a human being for the treatment of a disease such as atherosclerosis, thrombosis, restenosis, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, tumor obstruction, or combinations thereof. | 2009-10-15 |
20090258030 | Materials and Methods for Improving Livestock Productivity - The subject invention provides methods for improving livestock health. In specific embodiments, the invention provides methods for accelerating and/or augmenting livestock growth; improving immunity; and enhancing fertility in livestock. To do so, the present invention provides materials and methods for administering a cysteamine compound to livestock. | 2009-10-15 |
20090258031 | IMMUNOSUPPRESSIVE POLYPEPTIDES AND NUCLEIC ACIDS - The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided. | 2009-10-15 |
20090258032 | METHODS AND COMPOSITIONS TARGETING VIRAL AND CELLULAR ITAM MOTIFS, AND USE OF SAME IN IDENTIFYING COMPOUNDS WITH THERAPEUTIC ACTIVITY - This invention provides methods of treating, reducing the incidence of, and inhibiting metastasis formation of carcinomas, sarcomas, Epstein-Barr virus-induced malignancies, B cell proliferative disorders, and mast cell activation disorders, comprising administering to a subject a compound that inhibits an interaction of a first protein and an immunoreceptor tyrosine-based activation motif (ITAM) of a second protein, and screening methods for identifying ITAM-inhibitory compounds and peptides. This invention also provides peptides that inhibit signaling by ITAMs. | 2009-10-15 |
20090258033 | HCV E1E2 vaccine compositions - HCV E1E2 compositions comprising E1E2 antigens, submicron oil-in-water emulsions and/or immunostimulatory nucleic acid sequences are described. The compositions can be used in methods of stimulating an immune response in a vertebrate subject. | 2009-10-15 |
20090258034 | Method of Inducing Mucosal Immune Response to Antigen with Dioscorea Polysaccharides Adjuvant - A method for inducing mucosal immune responses in a subject in need thereof to an antigen includes administering to the subject a vaccine composition including the antigen and a | 2009-10-15 |
20090258035 | AVIAN VIRUS VACCINES AND USES THEREOF - The present invention relates to poultry vaccines for prevention of Newcastle disease. | 2009-10-15 |
20090258036 | DENGUE TETRAVALENT VACCINE CONTAINING A COMMON 30 NUCLEOTIDE DELETION IN THE 3' -UTR OF DENGUE TYPES 1, 2, 3, AND 4 OR ANTIGENIC CHIMERIC DENGUE VIRUSES 1, 2, 3, AND 4 - The invention relates to a dengue virus tetravalent vaccine containing a common 30 nucleotide deletion (Δ30) in the 3′-untranslated region of the genome of dengue virus serotypes 1, 2, 3, and 4, or antigenic chimeric dengue viruses of serotypes 1, 2, 3, and 4. | 2009-10-15 |
20090258037 | VACCINE DEVELOPMENT STRATEGY USING MICROGRAVITY CONDITIONS - Methods are provided herein for producing a vaccine, comprising culturing bacteria in microgravity. In some examples, the method includes culturing bacteria in microgravity, evaluating RNA expression, detecting an RNA that is over- or underexpressed during culture in microgravity, deleting the over- or underexpressed RNA in bacteria, and killing or attenuating the bacteria to produce a vaccine. In other examples, the method comprises culturing bacteria in microgravity, evaluating RNA expression, detecting a RNA that is over- or underexpressed during culture in microgravity, selecting bacteria that over- or underexpress the RNA, culturing the selected bacteria, and killing the bacteria to produce a vaccine. Vaccine compositions produced by the disclosed methods are also contemplated. | 2009-10-15 |
20090258038 | WATER-SOLUBLE COMPOSITIONS OF BIOACTIVE LIPOPHILIC COMPOUNDS - Water-soluble compositions comprising a lipophilic compound and a solubilizing agent of the general formula:
| 2009-10-15 |
20090258039 | Method of administering a pharmaceutical active ingredient - A method for reducing the friability of soft substrates by applying an effective amount of a water soluble, polymeric dispersion to at least a portion of a treatment surface of the substrate, such that less than about 90% of the exterior surface has the dispersion applied thereto. | 2009-10-15 |
20090258040 | STEROID TREATMENT FOR HOT FLASHES - Embodiments of the invention relate to methods for treating individuals suffering from hot flashes by vomeronasally administering a therapeutically effective dosage of a steroid agent. The hot flashes may be a result of postmenopause or castration suffered by the individual. In many embodiments, the method for treating individuals suffering with hot flashes is provided by administering a steroid agent containing an estrene compound, such as 16α,17α-epoxy-10β-hydroxyestr-4-en-3-one, to the individual. In other embodiments, pharmaceutical compositions containing the steroid agent may be used to treat individuals suffering with hot flashes. Embodiments include methods for treating male castrates, as well as postmenopausal women and men, suffering from hot flashes by vomeronasally administering a steroid agent containing 16α,17α-epoxy-10β-hydroxyestr-4-en-3-one to levitate the hot flashes. | 2009-10-15 |
20090258041 | Protection of Oxidizable Agents - Formulations for cosmetical or pharmaceutical use contain an antioxidant in encapsulated form and a cosmetically or pharmaceutically acceptable carrier. The antioxidant is selected from carbon bridged hindered phenoles, ester bridged hindered phenoles, amide bridged hindered phenoles, lactones of hindered phenoles, sterically hindered oxylamines and sterically hindered hydroxylamines. The encapsulated antioxidant is of high activity and suitable to protect a further active ingredient, e.g. oxidizable natural substances, vitamins, fragrances, and extracts from plants fungi, algae or animals, from premature degradation, especially when coencapsulated together with the ingredient. The formulations are useful inter alia for the preparation of a cosmetical or pharmaceutical skin care or skin delivery formulation, injectable solution, infusion solution, eye drop, drinking solution, a dietary or enriched food, an oral care formulation, drinking gargles, in-halants, or as a food additive. | 2009-10-15 |
20090258042 | Encapsulated Active Materials Containing Adjunct Crosslinkers - It is an object of the present invention to provide a microcapsule product comprising an active material; said active material encapsulated by a polymeric material to provide a polymer encapsulated material wherein said polymeric material comprises an adjunct crosslinker. | 2009-10-15 |
20090258043 | Dispersions Comprising Acylglutamates - The invention relates to dispersions comprising water, lipophilic phase and emulsifier, characterized in that the emulsifier is present in an amount of less than or equal to 3% by weight based on the total weight of the dispersion, and in that the emulsifier comprises at least one acylglutamate. The dispersions of the invention are suitable for cosmetic and/or pharmaceutical preparations. | 2009-10-15 |
20090258044 | Kit for insect bites - A travel kit used for inhibiting and reducing the incidence and effect of insect bites. The kit includes a pouch for enclosing a plurality of containers therein. The pouch has a closure means to maintain the containers in the pouch and a means for removably attaching the pouch to a person. The plurality of containers includes a first container containing at least one oral tablet comprising an effective amount of niacin (vitamin B-3) or its corresponding amide for inhibiting or reducing the incidence of insect bites. A second container is provided which contains a soap composition that includes an effective antimicrobial compound that when applied to a bite area of a person's skin that has an insect bite disinfects such bite area. A third container contains a mud composition that includes an effective amount of a clay that when applied to the bite area reduces the swelling, inflammation or itching of the bite area. A fourth container is provided which contains an effective sterilizing wash composition that when applied to the bite area sterilizes the bite area and assists in reducing the swelling, inflammation or itching of the bite area. Optionally, the kit further includes a fifth container containing at least one oral tablet comprising an effective amount of an antihistamine. | 2009-10-15 |
20090258045 | STRUCTURES INCLUDING ANTIMICROBIAL PEPTIDES - A structure includes a substrate and a first plurality of bilayers on the substrate. The first plurality of bilayers includes a first layer including an antimicrobial peptide having a charge, and a second layer including a polyelectrolyte having a charge opposite the charge of the first layer. At least a portion of the structure is capable of degrading by sequential removal of the first layer and the second layer, and releasing the antimicrobial peptide from the structure. | 2009-10-15 |
20090258046 | COMPOSITION, FORMULATIONS AND KIT FOR TREATMENT OF RESPIRATORY AND LUNG DISEASE WITH NON-GLUCOCORTICOID STEROIDS AND/OR UBIQUINONE AND A BRONCHODILATING AGENT - A pharmaceutical or veterinary composition, which comprises a first active agent selected from a non-glucocorticoid steroid or analogues, a ubiquinone, or salts thereof, and a second active agent comprising a bronchodilator. The composition is provided in various formulations and in the form of a kit. The products of this patent are applied to the prophylaxis and treatment of respiratory, lung and malignant diseases. | 2009-10-15 |
20090258047 | Heparin Prodrugs and Drug Delivery Stents Formed Therefrom - A prodrug comprising a heparin and a drug is provided. The prodrug can be used to form a coating on a medical device. The prodrug can also be used with a polymeric material to form a coating on a medical device. The polymeric material can be a hydrophobic polymer, a hydrophilic polymer, a non-fouling polymer, or combinations thereof. The medical device can be implanted in a human being for the treatment of a disease such as atherosclerosis, thrombosis, restenosis, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, tumor obstruction, or combinations thereof. | 2009-10-15 |
20090258048 | Self-Assembling Monomers and Oligomers as Surface-Modifying Endgroups for Polymers - Polymers having the formula R(LE) | 2009-10-15 |
20090258049 | DRUG ELUTING EXPANDABLE DEVICES - The present disclosure relates to drug eluting devices, and their uses. The drug eluting devices can allow for perfusion during deployment. The coatings the may contain bioactive materials which elute once deployed in a patient and can have anti-proliferative, anti-inflammation, or anti-thrombotic effects. Sol gel technology can be used to coat the devices. | 2009-10-15 |
20090258050 | Controlled Drug Delivery Using a Zein Layer Modified with Levulinic Acid - The disclosure relates to medical devices coated with zein admixed with levulinic acid. The medical device may further include a therapeutic agent in contact with zein admixed with levulinic acid. Zein admixed with levulinic acid allows the therapeutic agent to be retained on the device during delivery and also controls the elution rate of the therapeutic agent following implantation. The disclosure further relates to methods of delivering a therapeutic agent on said medical devices as well as their use especially in the form of stents for prevention of restenosis. | 2009-10-15 |
20090258051 | Microbes Encapsulated Within Crosslinkable Polymers - The invention relates to porous films comprising crosslinked electrospun hydrogel fibers. Viable microbes are encapsulated within the crosslinked electrospun hydrogel fibers. The crosslinked electrospun hydrogel fibers are water insoluble and permeable. The invention also relates to methods of making and using such porous films. | 2009-10-15 |
20090258052 | COMPOUNDS AND METHODS FOR ALTERING BONE GROWTH - The present invention provides compounds, compositions and methods for promoting bone growth. Compounds useful in the methods of the present invention include the following: | 2009-10-15 |
20090258053 | MEDICAL STENT PROVIDED WITH A COMBINATION OF MELATONIN AND PACLITAXEL - A stent provided with a composition comprising melatonin and paclitaxel is described. The described stent is useful in treating smooth muscle cell proliferation, such as stenosis and preventing restenosis in vascular vessels. | 2009-10-15 |
20090258054 | Heparin Prodrugs and Drug Delivery Stents Formed Therefrom - A prodrug comprising a heparin and a drug is provided. The prodrug can be used to form a coating on a medical device. The prodrug can also be used with a polymeric material to form a coating on a medical device. The polymeric material can be a hydrophobic polymer, a hydrophilic polymer, a non-fouling polymer, or combinations thereof. The medical device can be implanted in a human being for the treatment of a disease such as atherosclerosis, thrombosis, restenosis, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, tumor obstruction, or combinations thereof. | 2009-10-15 |
20090258055 | Heparin Prodrugs and Drug Delivery Stents Formed Therefrom - A prodrug comprising a heparin and a drug is provided. The prodrug can be used to form a coating on a medical device. The prodrug can also be used with a polymeric material to form a coating on a medical device. The polymeric material can be a hydrophobic polymer, a hydrophilic polymer, a non-fouling polymer, or combinations thereof. The medical device can be implanted in a human being for the treatment of a disease such as atherosclerosis, thrombosis, restenosis, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, tumor obstruction, or combinations thereof. | 2009-10-15 |
20090258056 | SYSTEMS AND METHODS FOR PREPARING AUTOLOGOUS FIBRIN GLUE - A method of regenerating tissue in a living organism. The method includes the act of contacting an affected area of the living organism with a solid-fibrin web, the solid-fibrin web comprising platelets that release growth factors about one minute after contact to regenerate the tissue in the living organism. | 2009-10-15 |
20090258057 | Synthetically Functionalized Living Cells - Uniform, functional polymer patches can be attached to a fraction of the surface area of living individual cells. These surface-modified cells remain viable after attachment of the functional patch. The patch does not completely occlude the cellular surface from the surrounding environment. Functional payloads carried by the patch may include, for example, drugs or other small molecules, peptides, proteins, thermally responsive polymers, and nanoparticles, or any other material that can be incorporated in a polymer patch of subcellular dimensions. The patch can include one or more polyelectrolyte multilayers (PEMs). | 2009-10-15 |
20090258058 | NOVEL SILICONE FILM FORMER FOR DELIVERY OF ACTIVES - The invention provides: a film-forming composition comprising a) a saccharide-siloxane copolymer; b) a crosslinking agent; c) one or more active/inactive ingredients; and d) optionally, a solvent, or solvent mixture, wherein the saccharide-siloxane copolymer has the following formula: R | 2009-10-15 |
20090258059 | Stabilized foam for medical PSA substrate - The present invention provides a method for using a stabilized foam that is a crosslinked, closed cell polyolefin having a stabilizing layer and an adhesive layer. The method can be used for treating a wound, scrape, abrasion or skin puncture, for maintaining cleanliness of an operation incision site, suture site, catheter insertion site, or an intentional skin breach site, for monitoring electrical impulses during an EKG or for delivering electrical impulses in TENS or biofeedback therapy, and for reducing scar formation by softening collagen deposits. | 2009-10-15 |
20090258060 | Hydrogel Compositions - Hydrogel compositions are provided (a) that have a continuous hydrophobic phase and a discontinuous hydrophilic phase, (b) that have a discontinuous hydrophilic phase and a continuous hydrophilic phase, or (c) that are entirely composed of a continuous hydrophilic phase. The hydrophobic phase, if present, is composed of a hydrophobic polymer, particularly a hydrophobic pressure-sensitive adhesive (PSA), a plasticizing elastomer, a tackifying resin, and an optional antioxidant. The discontinuous hydrophilic phase, if present, is composed of a crosslinked hydrophilic polymer, particularly a crosslinked cellulosic polymer such as crosslinked sodium carboxymethylcellulose. For those hydrogel compositions containing a continuous hydrophilic phase, the components of the phase include a cellulose ester composition or an acrylate polymer or copolymer, and a blend of a hydrophilic polymer and a complementary oligomer capable of hydrogen bonding thereto. Films prepared from hydrogel compositions containing or entirely composed of the aforementioned continuous hydrophilic phase can be made translucent, and may be prepared using either melt extrusion or solution casting. A preferred use of the hydrogel compositions is in wound dressings, although numerous other uses are possible as well. | 2009-10-15 |
20090258061 | ONCE-A-DAY REPLACEMENT TRANSDERMAL ADMINISTRATION OF FENTANYL - A method and a daily replacement patch for transdermally administering an opioid for analgesic effect. The patch is applied to a subject to deliver the opioid through the skin. The patch may be replaced daily and over an extended period of time. | 2009-10-15 |
20090258062 | Transdermal Therapeutic System Comprising Active Ingredient Particles and Having Increased Active Ingredient Flux - The invention relates to a transdermal therapeutic system, preferably a transdermal patch, having an active ingredient-containing matrix formed substantially of a water-insoluble base material, such as rubber and synthetic polymers, into which is incorporated water-soluble and/or water-swellable inclusion bodies, e.g. inclusion bodies formed from polyvinyl alcohol or polyethylene glycol, that further include micronized or nanoscale active ingredient particles. | 2009-10-15 |
20090258063 | Transdermal patch - The present invention provides a transdermal patch having excellent preservation stability and transdermal absorbency of DMAEs. The patch has a support and a plaster layer integrally laminated on one surface of the support, and the plaster layer includes: DMAEs; an acrylic adhesive prepared by copolymerizing monomers respectively containing 30 to 99% by weight of alkyl methacrylate having an alkyl group with a carbon number of 6 to 22 and 1 to 70% by weight of alkyl acrylate having an alkyl group with a carbon number of 2 to 20; and fatty acid ester prepared by dehydro-condensing saturated fatty acid having an alkyl group with a carbon number of 10 to 20 and saturated aliphatic monohydric alcohol having an alkyl group with a carbon number of 2 to 20, wherein solubility of the DMAEs is 0.05 to 5 g at 25° C. with respect to the fatty acid ester. | 2009-10-15 |
20090258064 | COMPOSITIONS OF UCP INHIBITORS, FAS ANTIBODY, A FATTY ACID METABOLISM INHIBITOR AND/OR A GLUCOSE METABOLISM INHIBITOR - Systems and methods for treating inflammatory and proliferative diseases, and wounds, using as a pharmacon a UCP and/or Fas antibody or other inhibitor, or combination thereof, and a therapeutically acceptable amount of a fatty acid metabolism inhibitor and/or a therapeutically acceptable amount of a glucose metabolism inhibitor, optionally in combination with one or more chemotherpeutic agents. In preferred embodiments, the invention combines an antibody against UCP and/or Fas antigen with an oxirane carboxylic acid, represented by etomoxir, and/or with a 2-deoxyglucose compound, represented by 2-deoxy-D-glucose. The systems and methods of the invention can be used to treat drug-resistant or multi-drug resistant cancers. | 2009-10-15 |
20090258065 | Dermatological compositions comprising avermectin nanocapsules - Compositions and nanoemulsions containing lipid nanocapsules dispersed in a hydrophilic phase, such nanocapsules including at least one avermectin compound, are useful for the treatment of dermatological pathologies, e.g., rosacea. | 2009-10-15 |
20090258066 | COMPOSITIONS COMPRISING WEAKLY BASIC DRUGS AND CONTROLLED-RELEASE DOSAGE FORMS - The present invention is directed to pharmaceutical compositions, and methods of making such compositions, comprising microparticles containing a weakly basic drug core, a layer of alkaline buffer, and a controlled-release coating. The present invention is also directed to pharmaceutical dosage forms, including orally disintegrating tablets, conventional tablets, and capsules, and methods for their preparation. | 2009-10-15 |
20090258067 | MODIFIED RELEASE COMPOSITION OF AT LEAST ONE FORM OF VENLAFAXINE - The present invention relates to a modified release composition of at least one form of venlafaxine, which is an enhanced absorption delayed controlled release composition. The composition comprises a core comprising at least one form of venlafaxine, less than 10% of a gelling agent and a pharmaceutically acceptable excipient. The composition further comprises a modified release coating which substantially surrounds the core which provides a delayed controlled release of the at least one form of venlafaxine. | 2009-10-15 |
20090258068 | Titanium Oxide-Zinc Oxide Aggregate Powder And Production Method Thereof - The present invention provides a powder that can display excellent protection ability in both UV-A and UV-B regions. The titanium oxide-zinc oxide aggregate powder comprises an aggregate formed by the aggregation of porous titanium oxide particles and zinc oxide particles, and said porous titanium oxide particle is an aggregate of primary fine particles of titanium oxide. The production method of the titanium oxide-zinc oxide aggregate powder comprises the steps of: (a) hydrolyzing, with heating, an aqueous solution containing a titanium salt and an aliphatic alcohol; (b) adding a water-soluble zinc salt to a suspension of a precipitate obtained by the hydrolysis with heating in step (a), and then neutralizing the suspension with an alkali; and (c) calcining a precipitate obtained by the neutralization in step (b). | 2009-10-15 |
20090258069 | Delivery of LFA-1 antagonists to the gastrointestinal system - The present invention provides compositions and methods for treating disorders and diseases by delivery of LFA-1 antagonists to the gastrointestinal system. Methods include delivery of LFA-1 antagonists to effect localized treatment. | 2009-10-15 |
20090258070 | Topical LFA-1 antagonists for use in localized treatment of immune related disorders - This invention provides specifically formulated LFA-1 antagonists or pharmaceutically acceptable salts thereof that are suitable for topical delivery. In particular, the LFA-1 antagonists are particularly well suited for localized treatment by having a rapid systemic clearance rate. The invention also encompasses methods of treatment and prevention of immune related disorders using the LFA-1 topical formulations of the present invention. | 2009-10-15 |
20090258071 | COMPOSITIONS AND METHODS FOR PH TARGETED DRUG DELIVERY - The invention provides compositions and methods for the targeted, in particular, pH targeted, delivery of pharmaceutically active agents in mammals. The compositions comprise pH sensitive diblock copolymers, which permit the release of the pharmaceutically active agent when exposed to an environment having a particular pH. The compositions are particularly useful for the oral delivery of water insoluble pharmaceutically active agents. | 2009-10-15 |
20090258072 | LARGE ULTRAVIOLET ATTENUATING PIGMENTS - Large particle sunscreen powders useful as ingredients in cosmetic compositions and in dispersions for incorporation into cosmetic compositions comprise a UV shielding agent in a matrix material. The macroparticle powders can be used in a wide range of cosmetic formulations, including sunscreens, eyeshadow, mascara, foundation, blusher, toner, lipstick and other compositions requiring ultraviolet protection. | 2009-10-15 |
20090258073 | MAGNETIC CARRIER AND MEDICAL PREPARATION FOR CONTROLLABLE DELIVERY AND RELEASE OF ACTIVE SUBSTANCES, METHODS OF THEIR PRODUCTION AND METHODS OF TREATMENT USING THEREOF - The present invention relates to magnetic carriers and medical preparations for controllable delivery and release of active substances. The carrier for active substances comprises material A, which is magnetically or electrically sensible, and material B capable of controlling the retention/release rate of the said active substance from the said carrier, the said retention/release rate being temperature dependent; wherein the material B is in thermal contact with material A, and wherein the material A has magnetocaloric or electrocaloric effect sufficient to substantially vary the said retention/release rate of the active substance from the carrier. The invention further provides methods for controllable delivery and release of active substances in a predetermined place and at a predetermined time, and methods of treatment using these carriers. Methods of production of magnetic carriers are also proposed. | 2009-10-15 |
20090258074 | MIXTURES OF TANNINS, THEIR PRODUCTION AND USE IN MEDICAMENTS OR AS DISINFECTANTS - The invention relates to a mixture comprising
| 2009-10-15 |
20090258075 | Respiratory Drug Condensation Aerosols and Methods of Making and Using Them - Described herein are respiratory drug condensation aerosols and methods of making and using them. Kits for delivering condensation aerosols are also described. The respiratory drug aerosols typically comprise respiratory drug condensation aerosol particles. In some variations the respiratory drug compound is selected from the group consisting of β-adrenergics, methylxanthines, anticholinergics, corticosteroids, mediator-release inhibitors, anti-leukotriene drugs, asthma inhibitors, asthma antagonists, anti-endothelin drugs, prostacyclin drugs, ion channel or pump inhibitors, enhancers, or modulators and pharmaceutically acceptable analogs, derivatives, and mixtures thereof. Methods of treating a respiratory ailment using the described aerosols are also described. In general, the methods typically comprise the step of administering a therapeutically effective amount of respiratory drug condensation aerosol to a person with a respiratory ailment. Methods of forming a respiratory drug condensation aerosol are also described. The methods comprise the steps of vaporizing and condensing a respiratory drug composition. | 2009-10-15 |
20090258076 | WATER-SOLUBLE MAGNETIC OR METAL OXIDE NANOPARTICLES COATED WITH LIGANDS, PREPARATION METHOD AND USAGE THEREOF - This invention provides water-soluble magnetic or water-soluble metal oxide nanoparticles, which are coated with phase transfer ligands having an adhesive region, an adhesive region-crosslinking region, or an adhesive region-reactive region, and also provides a method of preparing water-soluble magnetic or metal oxide nanoparticles, the method including (1) synthesizing water-insoluble magnetic or metal oxide nanoparticles in an organic solvent; (2) dissolving the water-insoluble magnetic or metal oxide nanoparticles in a first solvent and dissolving a phase transfer ligand in a second solvent; and (3) mixing the two solutions achieved in step (2) to thus exchange the surface of the water-insoluble magnetic or metal oxide nanoparticles with the phase transfer ligand. Further, the water-soluble magnetic and water-soluble metal oxide nanoparticles coated with the phase transfer ligand can be used in various fields, including the separation and detection of materials, the diagnosis and treatment of diseases, and the decomposition of microorganisms and contaminants. | 2009-10-15 |
20090258077 | COMPOSITION AND METHOD FOR TREATING OR PREVENTING WHITE SPOT SYNDROME VIRUS - The present invention relates to a composition and method for treating or preventing white spot syndrome virus of arthropod. The present invention is based on using | 2009-10-15 |
20090258078 | ANTIOXIDANT POLYMER NANOCARRIERS FOR USE IN PREVENTING OXIDATIVE INJURY - The present invention is a method for encapsulating active protein in a polymeric nanocarrier. The instant method employs homogenization at subzero temperatures so that enzyme activity is retained. Enzymes which can be encapsulated by the present method include, for example, antioxidant enzymes and xenobiotic detoxifying enzymes. Encapsulation of an enzyme protects it from protease degradation and increases therapeutic half-life. Advantageously, polymeric nanoparticles of the invention are permeable to enzyme substrates and therefore enzymes encapsulated by the instant method can exert their effect without release from the nanocarrier. Methods for decomposing a reactive oxygen species, protecting against vascular oxidative stress, and detoxifying a xenobiotic are also provided. | 2009-10-15 |
20090258079 | Biocompatible Block Copolymer, Use Thereof and Manufacturing Method Thereof - A biocompatible block copolymer having a hydrophobic segment composed of amino acid and hydroxycarboxylic acid and a hydrophilic segment composed of polyalkylene oxide, wherein the terminal not bonded to the hydrophilic segment of the hydrophobic segment is composed of an amino acid unit. | 2009-10-15 |
20090258080 | EMU OIL AND FRUIT COMPOSITION - A composition is provided comprising emu oil and processed whole fruit. The composition is in a form for either topical application to human skin or for internal ingestion. | 2009-10-15 |
20090258081 | NEW PLANT DERIVED SEED EXTRACT RICH IN ESSENTIALLY FATTY ACIDS DERIVED FROM SALVIA HISPANICA L. SEED: COMPOSITION OF MATTER, MANUFACTURING PROCESS AND USE | 2009-10-15 |
20090258082 | Dried amnion and method for drying teatment of amnion - The present invention provides a dried amnion which is dried with maintaining tissues of a raw amnion and can be easily stored for a prolonged period of time. An amnion which is dried with maintaining cells and tissues of a raw amnion can be produced by repeating a pressure-reducing operation and a pressure-recovery operation several times, the pressure-reducing operation comprising continuously heating a raw amnion placed in a treatment vessel by a far-infrared heater provided in the treatment vessel and reducing the pressure of the inside of the treatment vessel, and the pressure-recovery operation comprising recovering the reduced pressure of the inside of the treatment vessel with heating the amnion by microwaves irradiated from a microwave heating apparatus provided outside of the treatment vessel, and the amnion is characterized by retaining basement membranes and connective tissues which are constituents of the raw amnion. | 2009-10-15 |
20090258083 | METHOD OF PRODUCING AND APPLICATIONS OF COMPOSITION OF HYPOCHLOROUS ACID - A method for preparing a stabilized antimicrobial hypochlorous acid solution by diluting an aged stock solution to provide a hypochlorous acid solution at a concentration of about 50 to about 7000 ppm at a pH range of about 2.8 to about 4.0. The antimicrobial hypochlorous acid solution maintains at least 75 percent of the available chlorine present over a period of about 6 months to about 12 months. The antimicrobial hypochlorous acid solution has medical applications in humans and veterinary practice, both prophylactic and therapeutic. The solution can also be used for non-medical applications in antisepsis and sterilization of surfaces. | 2009-10-15 |
20090258084 | Mono and Combination Therapy with a M1/M4 Muscarinic Agonist (Sabcomeline) for Treatment of Cognitive Disorders in Schizophrenia - The invention relates to the use of a functional muscarinic M1/M4 receptor agonist such as the functional muscarinic M1/M4 receptor agonist or a pharmaceutically acceptable salt thereof, in particular sabcomeline or a pharmaceutically acceptable salt thereof in for the treatment of cognitive impairment in schizophrenia and to combination therapies for the treatment of cognitive impairment in schizophrenia which the functional muscarinic M1/M4 receptor agonist or a pharmaceutically acceptable salt thereof, in particular sabcomeline or a pharmaceutically acceptable salt thereof and at least one other neuroprotective agent and/or neuroleptic and/or atypical antipsyhcotic agent are administered adjunctively or simultaneously. The invention provides methods of treatment of cognitive impairment in schizophrenia utilising such therapies and such adjunctive or simultaneous therapeutic combination therapies, therapeutic combinations for use therein and pharmaceutical compositions comprising them. | 2009-10-15 |
20090258085 | Emulsions and methods of their production - An emulsion including Dead Sea water is provided, as well as methods for making and using such an emulsion. The emulsion can also include a structured surfactant. | 2009-10-15 |
20090258086 | BIOFILM EXTRACELLULAR POLYSACCHARIDE SOLVATING SYSTEM - The invention provides a solvating system for the removal of biofilms which solvates the extracellular polysaccharide matrix holding it to a surface. The aqueous solvating system comprises water, a metal ion sequestering agent, and a solvating agent for an extracellular polysaccharide matrix, which is gentle enough to be used directly on human tissues, but which may also be used on hard or soft non-tissue surfaces to breakdown, and/or remove biofilms. | 2009-10-15 |
20090258087 | Method to increase and accelerated rehabilitate the capacity for work - The method to increase and accelerated rehabilitate the capacity for work is characterized in that the person is exposed to gaseous products having the property to improve physical and psychological human capabilities during a period of preparing for extreme strains and/or after extreme strains; the exposure to gaseous products is performed during a period from several weeks to several minutes before undergoing extreme strains by inhaling the gaseous mixture composed of oxygen and/or air and at least one inert gas, mainly xenon, with the contents of oxygen or air from 20% to 98% and at least one inert gas from 2% to 80%. The inhalation with the gaseous mixture is carried out until the state of euphoria emerges but no longer than for 20 minutes with breaks or without them; preferably, the inhalation with the gaseous mixture is performed no less than for 10 seconds and no longer than for 20 minutes with breaks or without them. Permanent and accelerated rehabilitation of the organism's capabilities and work capacity improvement during preparatory periods for extreme strains and in the course of extreme stressful strains as well as prompt rehabilitation of the diminished organism after extreme physical strains is provided due to the impact of gaseous products, i.e. oxygen cocktails having the property to improve human physical and psychological abilities and relieve mental, emotional and physical strain, pain and tiredness. | 2009-10-15 |
20090258088 | USE OF MATERIALS AND EXTERNAL STIMULI FOR SYNOVECTOMY - This invention has as one of its aspects a method to provide a safe an effective treatment for synovectomy. The method involves the administration a material to the affected joint, allowing the material to localize in the synovial membrane, and then applying an external stimulus that interacts with the material to provide therapy. The materials of this invention are preferably particles, which are either magnetic or contain a heavy element. The external stimuli of this invention includes an alternating magnetic field to heat magnetic particles, infrared laser to heat heavy elements, or electromagnetic ionizing radiation (X- or gamma-radiation) that interacts with heavy elements to produce a localized radiation dose. | 2009-10-15 |
20090258089 | Chemo- and Radiation-sensitization of Cancer by Antisense TRPM-2 Oligodeoxynucleotides - Administration of antisense oligodeoxynucleotides (ODN) targeted against the testosterone-repressed prostate message-2 (TRPM-2) gene can reduce the amount of TRPM-2 in renal cell cancer (RCC) cells and other cancer cells, and as a result enhance chemosensitivity of these cells to chemotherapy agents and radiation. Thus, for example, the sensitivity of renal cell cancer cells to a chemotherapeutic agent can be increased by exposing renal cell cancer cells to a chemotherapeutic agent and an agent which reduces the amount of TRPM-2 in the renal cell cancer cells. This provides an improved method for treatment of renal cell cancer, which is generally resistant to treatment with known chemotherapy agents. | 2009-10-15 |
20090258090 | COLON CLEANSING SOLUTION - The field of colonic diagnostic and surgical procedures is hampered by the lack of optimal means available to cleanse the colon. A compromise between convenient, distasteful, solid or low volume, hyperosmotic solutions which cause considerable fluid and electrolyte imbalances in patients and large volume, difficult to consume, iso-osmotic solutions has had to be made heretofore. This invention describes a low volume, hyper-osmotic solution consisting of sulfate salts with and with out polyethylene glycol, and further comprising a sweetener and/or flavoring. Unlike prior art, this composition is useful for the cleansing of the bowel and, in lower volumes, as a laxative, without producing clinically significant changes in bodily function. | 2009-10-15 |
20090258091 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES - The present invention relates to compositions and methods for treating neurodegenerative diseases. In some embodiments, the present invention provides compositions for treating and preventing presbycusis. | 2009-10-15 |
20090258092 | Improved Tissue Maintenance - The invention provides a method of reducing damage to a tissue, organ or cell from surgical procedures comprising administering a composition comprising a potassium channel opener/agonist and/or an adenosine receptor agonist (eg. adenosine) together with a local anaesthetic (eg. lignocaine) when perfusing the organ. | 2009-10-15 |
20090258093 | Use of a brassocattleya marcella koss orchid extract as an active agent to prevent or delay the appearance of signs of cutaneous aging - The present invention describes the use of an extract from the | 2009-10-15 |
20090258094 | XANTHOHUMOL-ENRICHED HOP EXTRACT - A method for preparing a xanthohumol-rich hop composition. The method includes providing a solution that contains xanthohumol-containing hop substances and effecting precipitation of non-xanthohumol hop substances by adjusting both the salt concentration and pH value of the solution. The xanthohumol-rich hop composition prepared by this method can be used for treating various diseases, e.g., skin disorders, and bacterial infection. | 2009-10-15 |
20090258095 | Use of a Ginkgo Biloba Extract for the Treatment of Mitochondrial Disease of Genetic Origin - The invention relates to the use of | 2009-10-15 |
20090258096 | Anticancer Methods Employing Extracts of Gleditsia sinensis Lam - Selective apoptotic extracts of | 2009-10-15 |
20090258097 | EXTRACTS AND COMPOUNDS FROM "AGAPANTHUS AFRICANUS" AND THEIR USE AS BIOLOGICAL PLANT PROTECTING AGENTS - The invention relates to plant extracts, especially based on species of the genus | 2009-10-15 |
20090258098 | PENETRATING CARRIER, ANTIFUNGAL COMPOSITION USING THE SAME AND METHOD FOR TREATMENT OF DERMATOPHYTE INFECTIONS - An antifungal composition and penetrating carrier system for topical treatment of dermatophytic infection and secondary bacterial infections. The antifungal composition includes various fungistatic and fungicidal essential oil components, or combinations thereof. The penetrating carrier system may include various ingredients, including a penetration enhancer, such as isopropyl myristate. | 2009-10-15 |
20090258099 | Array of nozzles for extruding multiple cellulose fibers - An array of nozzles is disclosed for forming multiple cellulose fibers. Each nozzle has a longitudinal central axis and includes a tube with a cross-section having a diameter through which an aqueous solution of cellulose and a solvent can be extruded into a molten filament. A first opening is present which surrounds each of the tubes. The first opening has a cross-section with a diameter, and each of the first openings is capable of emitting a pressurized gas which surrounds one of the extruded molten filaments. At least three second openings are spaced away from each of the first openings. Each of the second openings is capable of emitting a pressurized gas stream essentially parallel to the longitudinal central axis of each of the nozzles, and each of the pressurized gas streams functions to shroud one of the extruded molten filaments. | 2009-10-15 |
20090258100 | Thermal Growth Compensating Extrusion Screw Assembly - An improved extrusion assembly is disclosed which better adapts to thermal changes resultant from the transport of high-temperature extrudate. An extrusion screw present in the assembly includes a hollow portion. A biasing member is disposed in the hollow portion. When the assembly is transporting high-temperature extrudate, the biasing member's included Belleville washer component compensates for the thermal expansion and contraction of the extrusion screw. | 2009-10-15 |
20090258101 | MULTI-LEVEL MACHINE FOR DUPLICATING A SECTIONED AND SCANNED BONE END AND FOR PRODUCING A FITTING IMPLANT REPLACEMENT - A machine for producing a three dimensional joint replacement article and which exhibits a three dimensional shaped body incorporating a scanner component for at least receiving a digitized input corresponding to a set of dimensions associated with a replacement article to be produced. Incorporated in die machine is a numerical control guided machining subassembly in communication with at least one material blank corresponding to an article to be produced. Material shavings are vacuum removed and collected for disposal and, following CNC machining, the finished part is deposited into a cavity accessed by a retrieval door for removal. | 2009-10-15 |
20090258102 | METHOD FOR FORMING TURBINE BLADE WITH ANGLED INTERNAL RIBS - A die for forming a lost wax ceramic core allows the formation of non-parallel separating spaces between adjacent portions of the core. The core will eventually form cooling channels in an airfoil. The die for forming the core includes a plurality of moving parts having rib extensions. At least some rib extensions are non-parallel to form the non-parallel spaces. The die includes two main die halves that come together to form several of the spaces. Inserts move with those die components and come together to form other spaces. At least one of the inserts contacts surfaces on one of the die halves, such that the non-parallel spaces are formed. | 2009-10-15 |
20090258103 | Multi-Head Extruder Assembly - An extruder that is adapted to provide a flow of an extrudate is provided. There is a frame having a plurality of storage positions, a discharge position and a plurality of extruder heads. Each extruder head is secured to the frame and is movable between one of the storage positions and the discharge position. A sealing member is provided that is secured to the extruder. The sealing member is adapted to move between an engaged position and a disengaged position, wherein the sealing member moves from the disengaged position to the engaged position so as to engage one of the extruder heads when it is in the discharge position. | 2009-10-15 |
20090258104 | MOLD STRUCTURE FOR MANUFACTURING OF SECURING FILM - The present invention relates to a mold structure for manufacturing a securing film, and in particular, to a mold structure for manufacturing a securing film by alternately stacking and coupling two thin circular plates having different diameters from each other and allowing a concave structure to be formed within a transparent synthetic resin film which is closely adhered to outer circumferential surfaces of the two plates according to a height difference between the outer circumferential surface of the plate having the larger diameter and the outer circumferential surface of the plate having the smaller diameter, and a securing film which is accurately manufactured by filling the concave structure of the transparent synthetic resin film with a colored ink and coating on the resulting outer circumferential surface a transparent synthetic resin film such as a polyethylene terephthalate (PET). | 2009-10-15 |
20090258105 | APPARATUS FOR EXTRUSION-BLOW MOLDING A BOTTLE FOR ASSEMBLY WITH METAL CAN END - An extrusion blow mold for forming a plastic bottle having a radial flange suitable for roll-form attachment to a metal can end. The mold has a pair of confronting mold halves, each mold half including a body forming portion, a bottom pinch-off portion located below the body forming portion, a top block portion including a blow chamber located above the body forming portion, and a spin-ring forming portion located between the body forming portion and the top block portion. The spin-ring forming portion includes a thread ring insert and a cutter ring insert. The thread ring insert has an inside upper edge including an outwardly extending surface terminating in a step defining a lower surface and a outer edge of a radial flange. The cutter ring insert is positioned immediately above the thread ring insert. The cutter ring insert has a lower surface adjacent an inside edge defining an upper surface of the radial flange including a tapered inner edge extending upward and inward from the step. At least one of the thread ring insert and cutter ring insert includes a relief surface connected to a vent channel to permit gas to escape from the area defining the radial flange. | 2009-10-15 |
20090258106 | Corn Wet Milling Process - A corn wet-milling process comprises steeping corn kernels in an aqueous liquid, which produces softened corn; milling the softened corn in a first mill, which produces a first milled corn; separating germ from the first milled corn, thereby producing a germ-depleted first milled corn; milling the germ-depleted first milled corn in a second mill, producing a second milled corn; separating the second milled corn into a first starch/protein portion that comprises starch and protein and a first fiber portion that comprises fiber, starch, and protein; milling the first fiber portion in a third mill, which produces a milled fiber material that comprises fiber, starch, and protein; separating at least some of the starch and protein in the milled fiber material from the fiber therein, producing a second fiber portion that comprises fiber and starch and a second starch/protein portion that comprises starch and protein; and contacting the second fiber portion with at least one enzyme to convert at least some of the starch therein to dextrose. The converted material is screened using one or more screens to separate the fiber from the liquor. The liquor can be fermented to ethanol, or refined to dextrose. The fiber can be pressed and dried as an animal feed. | 2009-10-15 |
20090258107 | Oral Tolerance Promotion With Glycated Proteins - A method of promoting oral tolerance to proteins in an animal comprising administering glycated forms of said proteins to the animal; glycated proteins for use in the promotion of oral tolerance in an animal; a food product comprising glycated proteins for use in the same; and a method for making said food product. | 2009-10-15 |
20090258108 | FOOD PRODUCT WITH AN ENCAPSULATED LECITHIN MATERIAL - A composition includes a first component containing phospholipids and a second component encapsulating the first component. The composition includes between about 10% and about 80% by weight phospholipids. The composition may be used in chewing gum to provide a gum cud that does not adhere to concrete and does not dissolve in the mouth while chewing. | 2009-10-15 |
20090258109 | OPTIMIZED SUGAR-FREE HARD COATING PROCESS - A novel process of hard coating, for creating a hard, crunchy coating on the surface of a product in less than two hours, includes a plurality of cycles each including: applying a coating syrup containing at least one polyol obtained by hydrogenation of disaccharides, and the coating syrup having 60%-90% solids content by weight and preferably 70%-85% by weight; drying by using air with a temperature of 40° C.-70° C., for a time of at least 1 minute and of not more than 5 minutes; the number of cycles being such that a degree of enlargement of greater than 25%, preferentially greater than 30% and more preferentially greater than 32% is obtained. One variant of the process according to the invention consists in adding, after applying the syrup, an amount of polyol powder of very high purity. The invention is also directed towards the coated products obtained by using the process. | 2009-10-15 |
20090258110 | Seed Koji for Brewing, Koji for Brewing, Brewed Foods and Method for Producing the Same - [PROBLEMS] To provide a seed koji for brewing, which is suitable for wheat allergy patients and wheat intolerance patients (patients with celiac disease) and the medium of which is completely free from wheat-origin component, a koji for brewing, brewed foods and a method of producing the same. [MEANS FOR SOLVING PROBLEMS] Whole soybeans are hulled. A koji mold belonging to the genus | 2009-10-15 |
20090258111 | HIGHLY BIOAVAILABLE ORAL ADMINISTRATION COMPOSITION OF CRYPTOXANTHIN - A composition having improved bioavailability, of cryptoxanthin derived from a natural product, particularly that derived from | 2009-10-15 |
20090258112 | USE OF PARTS OF THE BAOBAB PLANT AS ANIMAL FOOD OR AS ADDITIVE IN ANIMAL FOOD - The present invention relates to the use of plant parts of the genus | 2009-10-15 |
20090258113 | PELLET DRYING PROCESS - A method for making an expandable half-product or pellet suitable for cooking by microwave oven (or other method such as frying) that results in a non-uniform, random design, while having a distinct pattern or style. The half product design is achieved by inducing stress cracks in the half product. The stress cracks are created by a controlled drying process whereby extruded half-products are first case hardened to create an outer skin that requires an internal build-up of pressure to penetrate. After creation of the outer skin, by drying in an oven or in ambient air, the half-product is heated to permit the vapor pressure of the moisture inside the half-product to break through the outer skin and escape. Such escape points induce stress cracks in random places in the half-product. The general pattern of the stress cracks can be varied by manipulation of the time-temperature profile of the case hardening and stress cracking steps. | 2009-10-15 |
20090258114 | METHOD OF BREWING DIFFERENT TYPES OF BEVERAGES WITH A SINGLE BREWER - A method of brewing a fresh, hot beverage in a beverage brewer ( | 2009-10-15 |
20090258115 | PACKAGED FOOD PRODUCT - The present invention relates to a packaged food product ( | 2009-10-15 |
20090258116 | Packaged food product and method of packaging and identifying packaged products - The present invention relates to a custom-configured product and method of identifying packaged products and of distributing a packaged product. The method of labeling a product comprises creating a label which has an adhesive portion for adhering the label and indicia identifying a product; contacting the label adhesive with a first surface of the packaging, so that the label adheres to the surface; placing the product in the packaging, closing the packaging so that the indicia is visible to the customer examining the indicia to determine the destination for the product; and delivering the product to the destination. The labeled custom-configured product comprises: a custom-configured food product; a packaging containing the food product; the packaging having an interior surface and an exterior surface, where the interior surface is in contact with the food product; and a label having adhesive on a first face and indicia on a portion of a second face, the indicia identifying the food product, the adhesive adhering directly to the surface of the packaging, wherein the portion of the second face is visible outside the packaging so that a consumer can identify the food product from the indicia without opening the packaging. | 2009-10-15 |
20090258117 | PIPE MOLD AND PIN-BLOCK ASSEMBLY - A pipe mold assembly is composed of a mold and a pin block. The mold can be composed of two sides. The bottom side of the mold contains an insert for forming the bowl of the pipe. The insert can be conical shaped and indented to form a lip. A pin block is inserted between the top and bottom sides of the mold to create a smoking channel. The pin block can form a carburetor if the pins are long enough. The pipe is formed by placing the pin block on a flat surface, surrounding the pin block with the mold, and pouring an edible solution into the opening. Once the solution is sufficiently cool, the pin-block and mold are removed. | 2009-10-15 |
20090258118 | Coffee Package - Disclosed is a coffee package that includes a flavored coffee product, a container enclosing the flavored coffee product, and an aroma patch disposed on the container. The flavored coffee product includes a solid coffee material and a flavoring agent for providing a flavor of a tropical fruit. The aroma patch disposed on the container is capable of releasing an aroma of the flavored coffee product. Further disclosed is a coffee package including a flavored coffee beverage that includes a coffee material dissolved in a fluid. | 2009-10-15 |
20090258119 | POLYMER-COATED LIQUID PACKAGING BOARD, A PACKAGE FORMED FROM IT AND THE USE OF THE POLYMER - The object of the invention is a liquid packaging board ( | 2009-10-15 |
20090258120 | BEVERAGE DISPENSING DEVICE WITH FRESHNESS INDICATOR - The present invention is directed to a freshness indicator ( | 2009-10-15 |
20090258121 | METHOD OF PRODUCING NUTRITIONAL PRODUCTS FROM HUMAN MILK TISSUE AND COMPOSITIONS THEREOF - Methods of isolating, treating, storing and processing human milk, as well as nutritional formulations of human milk comprising protective human milk proteins. | 2009-10-15 |
20090258122 | Inline antimicrobial lightwave treatment method and apparatus - An inline antimicrobial lightwave treatment method and apparatus is provided. The method and related apparatus comprises a conveyor-based transport system that subjects all surfaces of foodstuff moving on a conveyor to a UV-ruby lightwave combination. In the preferred embodiment, the apparatus uses vertically-stacked conveyor belts to conserve floor space in industry food processing applications. The method is capable of realizing greater than 3 log reductions in live microbes in foodstuffs, although the technology may be used in nonfood applications. | 2009-10-15 |
20090258123 | PROCESS FOR PREPARING PARFRIED POTATOES FOR MICROWAVE HEATING - Potato pieces such as cut potato chunks are pre-processed by blanching, parfrying and freezing, followed by a surface-coating step wherein the potato pieces are coated with a blend of oil and lecithin. In a preferred form, the oil-lecithin blend comprises about 95% weight oil such as a soybean-based salad oil, and about 5% weight soybean-based lecithin. This oil-lecithin blend is applied to the pre-processed potato pieces as by spraying to achieve a product weight increase of from about 2% to about 8%. Such surface-coated frozen potato pieces are adapted for finish preparation by microwave heating, with the finish-prepared pieces exhibiting substantial and desirable external surface crispness in combination with clean and natural potato flavor. | 2009-10-15 |
20090258124 | Hydrolyzed liquid sweetener for livestock - The present invention includes a liquid sweetener made from a lactose containing liquid that can be used to coat animal feed to increase palatability. It also includes methods of making the liquid sweetener and making animal feed with increased palatability. The methods include hydrolyzing whey or whey derivatives and adding amino acids to promote a Maillard reaction to synthesize the sweetener. | 2009-10-15 |
20090258125 | Ozone Emitter, Method and Equipment for Producing the Ozone Emitter, and Method for Utilizing the Same - The present invention provides an ozone emitter, which can continue to emit ozone gas for a long time, which can continue to exert effective detergent and bactericidal action due to ozone gas for a long time, and which is easily portable, a method and equipment for producing the ozone emitter, and a method for utilizing the same. The ozone emitter is provided in such a manner that ozone gas is filled into a container which is obtained by forming an ozone gas impermeable film material in a container shape, wherein the film material is provided with a number of fine permeable pores through which molecules of ozone gas can permeate. | 2009-10-15 |